Stock CADENCE PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

News Cadence Pharmaceuticals, Inc.

Equities

US12738T1007

End-of-day quote Nasdaq
Other stock markets
- USD - Intraday chart for Cadence Pharmaceuticals, Inc.
2014 Actavis : Factbox - M&A frenzy transforming global pharma RE

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Actavis : Factbox - M&A frenzy transforming global pharma
RE
Cadence Pharmaceuticals, Inc. : Cadence Pharmaceuticals Reports Fourth Quarter and Full Year 2013 Financial Results
PR
Cadence Pharmaceuticals, Inc. : Ryan & Maniskas, LLP Announces Investigation of Cadence Pharmaceuticals Inc.
PR
Cadence Pharmaceuticals, Inc. : Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of Cadence Pharmaceuticals, Inc. Stockholders
BU
Cadence Pharmaceuticals, Inc. : Cadence Pharmaceuticals Estimates Fourth Quarter and Full Year 2013 Product Revenue and Provides Full Year 2014 Revenue Guidance
PR
Cadence Pharmaceuticals, Inc. : New Data Detailing Economic Impact of IV Acetaminophen in Treating Acute Pain to be Presented at Two Major Healthcare Conferences
PU
Cadence Pharmaceuticals, Inc. : Cadence Pharmaceuticals' CEO Ted Schroeder To Present At The 25th Annual Piper Jaffray Healthcare Conference On December 4, 2013
PR
Cadence Pharmaceuticals, Inc. : Drug Milestones, Favorable Ruling, Official Statement, and Quarterly Report - Research Report on BioMarin, Vanda, Cadence, Prana, and Biostar
PR
Cadence Pharmaceuticals, Inc. : Cadence Pharmaceuticals Reports Positive Outcome In OFIRMEV® Patent Litigation
PR
Cadence Pharmaceuticals, Inc. : Cadence Pharmaceuticals Recognized As A Top Workplace In San Diego Based On Employee Feedback
PR
Cadence Pharmaceuticals, Inc. : Cadence Pharmaceuticals Reports Third Quarter 2013 Financial Results
PR
Cadence Pharmaceuticals, Inc. : Cadence Pharmaceuticals To Host Conference Call And Webcast To Discuss Third Quarter 2013 Financial Results On November 5, 2013
PR
Cadence Pharmaceuticals, Inc. : Cadence Pharmaceuticals' CEO Ted Schroeder To Present At The Stifel Nicolaus Healthcare Conference 2013 On September 11, 2013
PR
Cadence Pharmaceuticals, Inc. : Cadence Pharmaceuticals Comments on USPTO's Non-Final, Initial Office Action on Reexamination of Patent
PR
Cadence Pharmaceuticals, Inc. : Cadence Pharmaceuticals Appoints Laureen DeBuono to its Board of Directors
PR
Cadence Pharmaceuticals, Inc. : Cadence Pharmaceuticals To Present At The 2013 Wedbush PacGrow Life Sciences Management Access Conference On August 13, 2013
PR
Cadence Pharmaceuticals, Inc. : Cadence Pharmaceuticals Reports Second Quarter 2013 Financial Results
PR
Cadence Pharmaceuticals, Inc. : Cadence Pharmaceuticals To Host Conference Call And Webcast To Discuss Second Quarter 2013 Financial Results On July 31, 2013
PR
Cadence Pharmaceuticals, Inc. : Cadence Pharmaceuticals To Present At The 8th Annual JMP Securities Healthcare Conference On July 9, 2013
PR
Cadence Pharmaceuticals, Inc. : Cadence Pharmaceuticals To Present At Three Investment Conferences During The Month Of May 2013
PR
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. Stock
  4. News Cadence Pharmaceuticals, Inc.